CASI Pharmaceuticals, Inc. (CASI): History, Ownership, Mission, How It Works & Makes Money

Ever wondered about the journey and workings of a biopharmaceutical company like CASI Pharmaceuticals, Inc.? This company is focused on developing and commercializing innovative therapeutics and pharmaceutical products. Keep reading to explore its history, ownership structure, mission, operational strategies, and revenue generation, offering a comprehensive understanding of CASI's role in the pharmaceutical landscape. In 2024, CASI reported a full-year revenue of $28.5 million and is strategically pivoting towards developing CID-103 for organ transplant rejection and autoimmune diseases.

CASI Pharmaceuticals, Inc. (CASI) History

CASI Pharmaceuticals Founding Timeline

Year established

CASI Pharmaceuticals, Inc. was established in 1997.

Original location

The company was originally located in Rockville, Maryland.

Founding team members

The information about the founding team members is not available in the provided context.

Initial capital/funding

Details regarding the initial capital or funding are not available in the provided context.

CASI Pharmaceuticals Evolution Milestones

CASI Pharmaceuticals Transformative Moments

CASI Pharmaceuticals has undergone several transformative moments that have shaped its strategic direction and focus. These include:

• Shift to Focus on China Market: The relocation of the company's headquarters to Beijing in 2014 marked a significant shift in strategy, emphasizing the importance of the Chinese pharmaceutical market.
• Product Expansion via Acquisitions and Licensing: Strategic acquisitions and licensing agreements, such as those for CBDrug and TCB-128, have broadened the company's product pipeline and therapeutic focus.
• Regulatory Milestones: FDA approval for EVOMELA in 2019 was a pivotal moment, validating the company's ability to navigate the regulatory landscape and bring products to market.

These moments reflect CASI Pharmaceuticals' evolution from its initial founding to its current position as a biopharmaceutical company focused on developing and commercializing innovative therapeutics, particularly in oncology. For more insights into the company's guiding principles, explore: Mission Statement, Vision, & Core Values of CASI Pharmaceuticals, Inc. (CASI).

CASI Pharmaceuticals, Inc. (CASI) Ownership Structure

Understanding the ownership structure of CASI Pharmaceuticals, Inc. provides insights into who controls the company and how it's governed. As a public company, its ownership is distributed among various shareholders.

CASI Pharmaceuticals, Inc. Current Status

CASI Pharmaceuticals Inc. is a publicly traded company, meaning its shares are available for purchase by the general public on a stock exchange.

CASI Pharmaceuticals, Inc. Ownership Breakdown

The ownership of CASI Pharmaceuticals is distributed among various shareholders, including institutional investors, individual investors, and company insiders. The following table summarizes the ownership breakdown:

CASI Pharmaceuticals, Inc. Leadership

The leadership team at CASI Pharmaceuticals, Inc. plays a crucial role in guiding the company's strategic direction and operations. Key members of the leadership team include:

• Wei-Wu He, Ph.D.: Chairman and Chief Executive Officer
• James E. Cassella: Chief Financial Officer

These individuals, along with other members of the executive team, are responsible for making key decisions that impact the company's performance and future growth. For more detailed insights into CASI Pharmaceuticals, Inc., consider exploring this resource: Exploring CASI Pharmaceuticals, Inc. (CASI) Investor Profile: Who’s Buying and Why?

CASI Pharmaceuticals, Inc. (CASI) Mission and Values

CASI Pharmaceuticals is dedicated to the development and commercialization of innovative therapeutics, focusing on addressing unmet medical needs in oncology. Its core values emphasize innovation, integrity, and a commitment to improving patients' lives.

CASI's Core Purpose

Official mission statement

CASI Pharmaceuticals' mission statement is to:

• Develop and commercialize a portfolio of innovative therapeutics.
• Focus on hematology-oncology and other areas of unmet medical need.
• Deliver significant value to patients, healthcare professionals, and shareholders.

Vision statement

While a specific formal vision statement may not be publicly available, CASI's strategic actions and communications suggest a vision focused on:

• Becoming a leading biopharmaceutical company specializing in innovative oncology therapies.
• Expanding its commercial reach and pipeline through strategic partnerships and acquisitions.
• Improving the standard of care and outcomes for patients with cancer.

Company slogan/tagline

CASI Pharmaceuticals does not have a widely publicized official slogan or tagline. However, considering their focus, an implied tagline could be:

• 'Innovating for Life'
• 'Advancing Cancer Care'
• 'Committed to Oncology'

To learn more about the company's investors, check out: Exploring CASI Pharmaceuticals, Inc. (CASI) Investor Profile: Who’s Buying and Why?

CASI Pharmaceuticals, Inc. (CASI) How It Works

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.

CASI's Product/Service Portfolio

CASI's Operational Framework

CASI Pharmaceuticals operates through a multi-faceted approach to bring pharmaceutical products to market:

• Product Acquisition and Licensing: CASI strategically acquires or licenses promising pharmaceutical products and technologies from other companies.
• Clinical Development: They conduct clinical trials to evaluate the safety and efficacy of their product candidates.
• Regulatory Approval: CASI seeks regulatory approvals from agencies like the FDA in the United States and the NMPA in China to commercialize their products.
• Commercialization: The company commercializes approved products through its own sales and marketing teams or through partnerships with other pharmaceutical companies.

CASI's Strategic Advantages

CASI Pharmaceuticals possesses several strategic advantages that contribute to its market position:

• Focus on China: CASI has a strong focus on the Chinese pharmaceutical market, which is one of the largest and fastest-growing in the world.
• Strategic Partnerships: The company has established partnerships with leading pharmaceutical companies and research institutions.
• Diverse Product Portfolio: CASI has a diverse portfolio of products and product candidates targeting multiple therapeutic areas.
• Experienced Management Team: CASI has an experienced management team with a proven track record of success in the pharmaceutical industry.

To gain more insights into the ownership and investment trends surrounding CASI Pharmaceuticals, Inc., consider exploring this resource: Exploring CASI Pharmaceuticals, Inc. (CASI) Investor Profile: Who’s Buying and Why?

CASI Pharmaceuticals, Inc. (CASI) How It Makes Money

CASI Pharmaceuticals, Inc. primarily generates revenue through the development, acquisition, and commercialization of pharmaceutical products, focusing on hematology-oncology therapies for the U.S. and China markets.

Revenue Breakdown

Business Economics

The business economics of CASI Pharmaceuticals are influenced by several key factors:

• Pricing Strategy: CASI employs a value-based pricing strategy for its products, focusing on the clinical benefits and competitive landscape. This approach aims to optimize revenue while ensuring market access.
• Market Access: Gaining and maintaining market access in both the U.S. and China is crucial. This involves navigating regulatory approvals, securing reimbursement, and establishing effective distribution channels.
• R&D Investment: A significant portion of CASI's expenses is dedicated to research and development. These investments are vital for expanding the product pipeline and sustaining long-term growth.
• Cost of Goods Sold (COGS): Managing the cost of goods sold is essential for maintaining profitability. This includes optimizing manufacturing processes and supply chain management.

Financial Performance

CASI Pharmaceuticals' financial performance can be assessed through the following key metrics:

• Revenue Growth: Monitoring the growth rate of product sales in both the U.S. and China is crucial for assessing the company's market penetration and acceptance.
• Gross Margin: The gross margin, which is revenue less the cost of goods sold, indicates the efficiency of the company's production and pricing strategies.
• Operating Expenses: Analyzing operating expenses, including R&D and SG&A (selling, general, and administrative expenses), helps evaluate the company's investment in future growth and operational efficiency.
• Net Income/Loss: The bottom line, net income or loss, reflects the overall profitability of the company. It is influenced by revenue, expenses, and other income/losses.
• Cash Flow: Monitoring cash flow from operations, investing, and financing activities provides insights into the company's liquidity and financial stability.

To gain a deeper understanding of CASI Pharmaceuticals, Inc.'s financial standing, explore Breaking Down CASI Pharmaceuticals, Inc. (CASI) Financial Health: Key Insights for Investors.

CASI Pharmaceuticals, Inc. (CASI) Market Position & Future Outlook

CASI Pharmaceuticals is strategically positioned to leverage its portfolio of innovative oncology assets and its established commercial infrastructure in China to drive future growth. However, the company faces challenges typical of the pharmaceutical industry, including regulatory hurdles and competition.

Competitive Landscape

Opportunities & Challenges

Industry Position

CASI Pharmaceuticals operates within the highly competitive pharmaceutical industry, specifically focusing on oncology and hematology. Its position is characterized by:

• A niche focus on acquiring, developing, and commercializing innovative therapeutics.
• A strategic emphasis on the Chinese market, where it has established a commercial infrastructure.
• A portfolio of approved and pipeline products targeting specific oncology indications.

For more insights into the company's guiding principles, explore: Mission Statement, Vision, & Core Values of CASI Pharmaceuticals, Inc. (CASI).